| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/11/2008 | US20080305074 Stem cell factor |
| 12/11/2008 | US20080305073 Therapeutic Agents for the Treatment of Hmgb1-Related Pathologies |
| 12/11/2008 | US20080305070 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 12/11/2008 | US20080305038 Transport of Nano-and Macromolecular Structures Into Cytoplasm and Nucleus of Cells |
| 12/11/2008 | DE202007018618U1 G-CSF-Flüssigformulierung G-CSF liquid formulation |
| 12/11/2008 | DE102007026877A1 Verwendung des Fibroblastenwachstumsfaktors 7 (Fgf7) und des Rezeptors Fgfr2b als Biomarker Use of the fibroblast growth factor 7 (FGF7) and the receptor FGFR2b as biomarkers |
| 12/11/2008 | DE102007026153A1 Stabile D-Dimer Flüssigzubereitung Robust D-dimer liquid preparation |
| 12/11/2008 | DE102007005192A1 Producing a peptide for triggering an autoimmune response in a vertebrate comprises preparing a peptide comprising at least one consensus sequence between between similar microbial and vertebrate sequences |
| 12/11/2008 | CA2727126A1 Nasal-administered vaccines using multi-screened nalt-targeting and phagocytic polypeptide transport sequences |
| 12/11/2008 | CA2690854A1 Means and methods for enhancing weight gain in poultry |
| 12/11/2008 | CA2690848A1 Estrogen receptor-related receptor gamma (erry) in bone and cartilage formation and methods and compositions relating to same |
| 12/11/2008 | CA2690725A1 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds) |
| 12/11/2008 | CA2690089A1 Methods and compositions for delivery of medicaments to the lungs |
| 12/11/2008 | CA2689986A1 Compositions and methods for treating the vertebral column |
| 12/11/2008 | CA2689909A1 Long-acting polymeric prodrugs of exendin |
| 12/11/2008 | CA2689518A1 A novel bone mass increasing agent |
| 12/11/2008 | CA2689476A1 Intranasal carbetocin formulations and methods for the treatment of autism |
| 12/11/2008 | CA2689302A1 Clostridial toxin netb |
| 12/11/2008 | CA2689242A1 Agent and method for treatment of cancer |
| 12/11/2008 | CA2689120A1 Targeted induction of aggregation of proteins with cross beta structures |
| 12/11/2008 | CA2688574A1 Cyclic peptide cxcr4 antagonists |
| 12/11/2008 | CA2688525A1 Biological tissue growth through induced tensile stress |
| 12/11/2008 | CA2688489A1 Inhibition of hiv-1 infection by potent metallocene conjugated peptide through conformational entrapment of envelope gp120 |
| 12/11/2008 | CA2688478A1 Slow release pharmaceutical composition made of microparticles |
| 12/11/2008 | CA2688161A1 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 12/11/2008 | CA2687683A1 Modified nucleotide sequence encoding glucagon-like peptide-1 (glp-1) |
| 12/11/2008 | CA2687368A1 Vaccine for the prevention of breast cancer relapse |
| 12/11/2008 | CA2687246A1 High temperature stable peptide formulation |
| 12/10/2008 | EP2000545A1 Compositions and methods for the diagnosis and treatment of tumor |
| 12/10/2008 | EP2000536A2 Tat-derived transport polypeptides |
| 12/10/2008 | EP2000483A2 Vegf receptor fusion protein and use thereof |
| 12/10/2008 | EP2000482A1 Compositions and methods for the diagnosis and treatment of tumor |
| 12/10/2008 | EP2000479A1 Genetic Sequences and Proteins Related to Alzheimer's Disease, and Uses Therefor |
| 12/10/2008 | EP2000478A1 Biologically active peptide and agent containing the same |
| 12/10/2008 | EP2000160A2 Method and apparatuses for determining the efficiency of dialysis |
| 12/10/2008 | EP2000149A1 Chimeric anti-CD20 antibody |
| 12/10/2008 | EP2000148A1 Compositions and methods for the diagnosis and treatment of prostate cancer |
| 12/10/2008 | EP2000143A2 Transdermal gel compositions containing testosterone and their use for the treatment of fibromyalgia, chronic fatigue syndrome, muscle pain or decreased libido |
| 12/10/2008 | EP1999269A2 Soluble monomeric ephrin a1 |
| 12/10/2008 | EP1999265A2 Fermentation processes |
| 12/10/2008 | EP1999146A2 Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation |
| 12/10/2008 | EP1999142A2 Multivalent clostridial toxins |
| 12/10/2008 | EP1998853A1 Healthy food product |
| 12/10/2008 | EP1998798A2 Method of manufacturing fibrous hemostatic bandages |
| 12/10/2008 | EP1998797A1 Master gene of arteriogenesis |
| 12/10/2008 | EP1998796A2 Gdf-9/bmp-15 modulators for the treatment of bone disorders |
| 12/10/2008 | EP1998795A2 Coronin 1 modulators for the treatment of autoimmune and lymphoproliferative disorders and mycobacterial infections |
| 12/10/2008 | EP1998794A2 Synthetic lipid rafts and methods of use |
| 12/10/2008 | EP1998793A1 Use of polypeptides having antimicrobial activity |
| 12/10/2008 | EP1998792A2 Methods and compositions related to cyclic peptide synthesis |
| 12/10/2008 | EP1998791A1 Suppression and treatment of neuropathic pain |
| 12/10/2008 | EP1998790A2 Compositions containing peptides with non-natural amino acids and methods of use |
| 12/10/2008 | EP1998789A2 Biomarkers for amyotrophic lateral sclerosis and methods using the same |
| 12/10/2008 | EP1998759A2 Combinations of hcv protease inhibitor(s) and cyp3a4 inhibitor(s), and methods of treatment related thereto |
| 12/10/2008 | EP1998637A1 Healthy food product |
| 12/10/2008 | EP1853292B1 Pharmaceutical composition comprising glutathione compounds and betalain for the prevention and treatment of cancer |
| 12/10/2008 | EP1817330B1 Protein allergen derivatives |
| 12/10/2008 | EP1804827B1 Methods for treating colon cancer with botulinum neurotoxin |
| 12/10/2008 | EP1765860B1 High affinity ny-eso t cell receptor |
| 12/10/2008 | EP1718659A4 Vectors having both isoforms of beta-hexosaminidase and uses of the same |
| 12/10/2008 | EP1716860A9 Preventive and therapeutic agent for chronic obstructive pulmonary disease |
| 12/10/2008 | EP1677827B1 Combinations for hcv treatment |
| 12/10/2008 | EP1675611B1 Therapeutic applications for c-peptide |
| 12/10/2008 | EP1670820B1 Antigens for an east coast fever vaccine |
| 12/10/2008 | EP1658046B1 Mucoadhesive composition comprising polyacrylate and chemoattractant |
| 12/10/2008 | EP1616019B1 Method for extracting collagen comprising microbial fermentation |
| 12/10/2008 | EP1608753B1 Antisense oligonucleotides (odn) against smad7 and uses in medical field thereof |
| 12/10/2008 | EP1606411B1 Mutant vesicular stomatitis viruses and use thereof |
| 12/10/2008 | EP1596881B1 Use of human chorionic gonadotropin in the treatment of symptoms caused by endometriosis |
| 12/10/2008 | EP1590001B1 Method for in vivo regulation of cardiac muscle contractility |
| 12/10/2008 | EP1534743B1 Scorpion peptide as hypotensive agent |
| 12/10/2008 | EP1487410B1 Preparation of sterile stabilized nanodispersions |
| 12/10/2008 | EP1403284B1 HAb18G/CD147, ITS ANTAGONIST AND APPLICATION |
| 12/10/2008 | EP1389123B1 A non-lethal method for extracting crude hemocyanin from gastropod molluscs |
| 12/10/2008 | EP1355920B9 Extractive purification of lipopeptide antibiotics |
| 12/10/2008 | EP1346722B1 Method for producing preparation containing bioactive substance |
| 12/10/2008 | EP1278549B1 Composition containing a cyclodextrin and a glycopeptide antibiotic |
| 12/10/2008 | EP1274450B1 Medical uses of agonsist and antagonists of IL-174 |
| 12/10/2008 | EP1267921B1 Composition and method for the prevention and/or the treatment of der pii allergy |
| 12/10/2008 | EP1221964B1 Antigenic modification of polypeptides |
| 12/10/2008 | EP1220913B1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 12/10/2008 | EP1218525B1 Utrophin gene promoter |
| 12/10/2008 | EP1212361B1 Preparation of highly pure non-toxic toxin fragments |
| 12/10/2008 | EP1182939B1 The combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements |
| 12/10/2008 | EP1163342B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/10/2008 | EP1042350B1 Inducible phosphofructokinase and the warburg effect |
| 12/10/2008 | EP1021464B1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 12/10/2008 | EP1018345B1 Water soluble dry compositions |
| 12/10/2008 | EP1005494B1 High avidity polyvalent and polyspecific reagents |
| 12/10/2008 | EP1002069B1 Peptides containing the motif igd and their use as cell migration modulators |
| 12/10/2008 | EP0972054B1 Enhancement of immune response using targeting molecules |
| 12/10/2008 | EP0804595B1 Resorbable synthetic proteins as implantables |
| 12/10/2008 | CN101322031A Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-alpha |
| 12/10/2008 | CN101321870A Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 12/10/2008 | CN101321863A Fusion proteins having a modulated half-life in plasma |
| 12/10/2008 | CN101321780A Insulin receptor antagonists and related compositions, uses and methods |
| 12/10/2008 | CN101321776A Process for the preparation of ferri-succinylcasein |
| 12/10/2008 | CN101321538A Interleukin-11 compositions and methods of use |
| 12/10/2008 | CN101319247A IL-2 selective agonists and antagonists |
| 12/10/2008 | CN101319244A Method of preparing glutathione freeze-dried powder |